Comments

Catalyst Pharmaceuticals

Q: What sector and industry does Catalyst Pharmaceuticals (CPRX) operate in?

Catalyst Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CPRXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$21.92

-0.88-3.86%

At close: -

$21.74

-0.18-0.82%

After Hours: Jan 10, 7:38 PM EDT

Catalyst Pharmaceuticals (CPRX) Forecast

News Earnings Catalyst Pharmaceuticals (CPRX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

100

0100

Financials Analysis

0100

Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Quotes, Forecast and News Summary

Catalyst Pharmaceuticals Stock (NASDAQ: CPRX) stock price, news, charts, stock research, profile.

Open	$22.85
Close	$21.92
Volume / Avg.	2.51M / 917.06K
Day Range	$21.34 - $22.98
52 Wk Range	13.12 - 24.27
Market Cap	$2.59B
P/E Ratio	19.32
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	-
Days to Cover	7.86

Recent News

Catalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical

Catalyst Pharmaceuticals settles patent litigation with Teva, delaying generic Firdapse launch until 2035. Legal actions against other defendants remain ongoing.

Vandana Singh

Avadel Obtains FDA Nod for Label Expansion Of Narcolepsy Drug Lumryz

Avadel Pharmaceuticals plc (NASDAQ:AVDL) announced that the FDA has approved its supplemental new drug application (sNDA) seeking label expansion of Lumryz.

Zacks

Top 3 Health Care Stocks That May Crash In August

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Nov 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$22.85
Close	$21.92
Volume / Avg.	2.51M / 917.06K
Day Range	$21.34 - $22.98
52 Wk Range	13.12 - 24.27
Market Cap	$2.59B
P/E Ratio	19.32
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	-
Days to Cover	7.86

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Catalyst Pharmaceuticals (CPRX) stock?

You can purchase shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) through any online brokerage.

View our list of the best stock brokerages

Who are Catalyst Pharmaceuticals (CPRX) competitors?

Other companies in Catalyst Pharmaceuticals’s space includes: Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), BeiGene (NASDAQ:ONC), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).

What is the forecast, or price target, for Catalyst Pharmaceuticals (CPRX) stock?

Catalyst Pharmaceuticals has a consensus price target of $29.50.

What is the current price for Catalyst Pharmaceuticals (CPRX)?

The stock price for Catalyst Pharmaceuticals (NASDAQ: CPRX) is $21.74 last updated January 10, 2025 at 7:38 PM EST.

Does Catalyst Pharmaceuticals (CPRX) pay a dividend?

There are no upcoming dividends for Catalyst Pharmaceuticals.

When is Catalyst Pharmaceuticals (NASDAQ:CPRX) reporting earnings?

Catalyst Pharmaceuticals’s Q4 earnings are confirmed for Wednesday, February 26, 2025.

Is Catalyst Pharmaceuticals (CPRX) going to split?

There is no upcoming split for Catalyst Pharmaceuticals.

What sector and industry does Catalyst Pharmaceuticals (CPRX) operate in?

Catalyst Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.